REFERENCES
- Panek WC, Holland GN, Lee DA, et al. Glaucoma in patients with uveitis. Br J Ophthalmol. 1990;74:223–227.
- Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–516.
- Heinz C, Koch JM, Zurek-Imhoff B, et al. Prevalence of uveitic secondary glaucoma and success of nonsurgical treatment in adults and children in a tertiary referral center. Ocul Immunol Inflamm. 2009;17:243–248.
- Herbert HM, Viswanathan A, Jackson H, et al. Risk factors for elevated intraocular pressure in uveitis. J Glaucoma. 2004;13:96–99.
- Pleyer U, Ruokonen P, Heinz C, et al. [Intraocular pressure related to uveitis]. Ophthalmologe. 2008;105:431–437.
- Heinz C, Pleyer U, Ruokonnen P, et al. [Secondary glaucoma in childhood uveitis]. Ophthalmologe. 2008;105:438–444.
- Moorthy RS, Mermoud A, Baerveldt G, et al. Glaucoma associated with uveitis. Surv Ophthalmol. 1997;41:361–394.
- Armaly MF, Becker B. Intraocular pressure response to topical corticosteroids. Fed Proc. 1965;24:1274–1278.
- Johnson D, Gottanka J, Flugel C, et al. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997;115:375–383.
- Lutjen-Drecoll E, Shimizu T, Rohrbach M, et al. Quantitative analysis of ‘plaque material’ in the inner- and outer wall of Schlemm’s canal in normal and glaucomatous eyes. Exp Eye Res. 1986;42:443–455.
- Sallam A, Sheth HG, Habot-Wilner Z, et al. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response. Am J Ophthalmol. 2009;148:207–213, e201.
- Benedikt O, Roll P, Zirm M. [The glaucoma in heterochromic cyclitis Fuchs. Gonioscopic studies and electron microscopic investigations of the trabecular meshwork (author’s transl)]. Klin Monatsbl Augenheilkd. 1978;173:523–533.
- Ito S, Karnowsky MJ. Formaldehyde-glutaraldehyde fixatives containing trinitro compounds. J Cell Biol. 1968;39:168a.
- Tektas OY, Lutjen-Drecoll E. Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res. 2009;88:769–775.
- Rohen JW, Lutjen-Drecoll E, Flugel C, et al. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res. 1993;56:683–692.
- Lutjen-Drecoll E. Morphological changes in glaucomatous eyes and the role of TGFbeta2 for the pathogenesis of the disease. Exp Eye Res. 2005;81:1–4.
- Rohen JW, Linner E, Witmer R. Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma. Exp Eye Res. 1973;17:19–31.
- Epstein DL, Hashimoto JM, Grant WM. Serum obstruction of aqueous outflow in enucleated eyes. Am J Ophthalmol. 1978;86:101–105.
- Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. 1987;28:477–481.
- Roth M, Simmons RJ. Glaucoma associated with precipitates on the trabecular meshwork. Ophthalmology. 1979;86:1613–1619.
- Fiore PM, Melamed S, Epstein DL. Trabecular precipitates and elevated intraocular pressure following argon laser trabeculoplasty. Ophthalmic Surg. 1989;20:697–701.
- Tektas OY, Hammer CM, Danias J, et al. Morphological changes in the outflow pathways of bovine eyes treated with corticosteroids. Invest Ophthalmol Vis Sci. 2010;51(8):4060–4066.
- Gottanka J, Johnson DH, Grehn F, et al. Histologic findings in pigment dispersion syndrome and pigmentary glaucoma. J Glaucoma. 2006;15:142–151.
- Snyder RW, Stamer WD, Kramer TR, et al. Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res. 1993;57:461–468.
- Steely HT, Browder SL, Julian MB, et al. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992;33:2242–2250.
- Tawara A, Tou N, Kubota T, et al. Immunohistochemical evaluation of the extracellular matrix in trabecular meshwork in steroid-induced glaucoma. Graefes Arch Clin Exp Ophthalmol. 2008;246:1021–1028.
- Welge-Lussen U, May CA, Lutjen-Drecoll E. Induction of tissue transglutaminase in the trabecular meshwork by TGF-beta1 and TGF-beta2. Invest Ophthalmol Vis Sci. 2000;41:2229–2238.
- Yun AJ, Murphy CG, Polansky JR, et al. Proteins secreted by human trabecular cells. Glucocorticoid and other effects. Invest Ophthalmol Vis Sci. 1989;30:2012–2022.
- Neumann C, Yu A, Welge-Lussen U, et al. The effect of TGF-beta2 on elastin, type VI collagen, and components of the proteolytic degradation system in human optic nerve astrocytes. Invest Ophthalmol Vis Sci. 2008;49:1464–1472.
- Gottanka J, Chan D, Eichhorn M, et al. Effects of TGF-beta2 in perfused human eyes. Invest Ophthalmol Vis Sci. 2004;45:153–158.
- Gottanka J, Johnson DH, Martus P, et al. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J Glaucoma. 1997;6:123–132.